TLR9 and neoplasm: Finally, the discrepancies between the in vitro-observed, unwanted tumor invasion-promoting effects and the favorable, most likely immune system-mediated anti-tumor effects of the synthetic TLR9-ligands are likely explained by the pharmacokinetics of these compounds.